from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0824c/desA1

LFCtreatmentdescriptionclass of inhibitor

1.041

Amikacinug/mL Amikacintranslation

1.224

Cap5-10ug/mL Capreomycintranslation

0.576

Rox10-50 ug/mL Roxithromycintranslation

0.579

SM2-5 ug/mL Streptomycintranslation

1.179

Tet5-10 ug/mL Tetracyclinetranslation

-1.242

Rif0.2-5ug/mL Rifampicintranscription

-0.460

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.120

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.458

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.340

CPZ10-50 ug/mL Chlorpromazinerespiration

0.541

Clofazimine10-13 ug/mL Clofaziminerespiration

0.379

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.296

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.981

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.379

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.524

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.534

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.944

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.320

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.030

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.197

KCN5-20 ug/mL Potassium cyaniderespiration

-0.789

NaN30.2-2 mM Sodium aziderespiration

-1.649

Nigericin50 uM Nigericinrespiration

-1.027

TRC10-150 ug/mL Triclosanrespiration

-1.176

TRZ10-25 ug/mL Thioridazinerespiration

1.259

Valinomycin0.5-10 uM Valinomycinrespiration

0.212

ZnSO42 mM ZnSO4respiration

-0.071

menadione6-10 ug/mL Menadionerespiration

0.312

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.260

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.725

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.715

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.401

NRP_1Non-replicating persistence stage 1dosRassociated

0.678

Amp0.2mg/mL AmpicillincellWall

0.519

Cephalexin20-100 ug/mL CephalexincellWall

-0.492

Cerulenin0.32-5 ug/mL CerulenincellWall

0.689

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.567

EMB10-20 ug/mL EthambutolcellWall

-0.745

Eta12-40 ug/mL EthionamidecellWall

-0.947

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.065

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.482

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.140

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.241

BZA0.12 mg/mL BenzamidearomaticAmides

0.819

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.892

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.371

H2O24 mM hydrogen peroxideDNAdamaging

0.816

Levo10 ug/mL LevofloxacinDNAdamaging

0.274

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.252

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.604

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.443

UVUV-irradiationDNAdamaging

-0.358

ARP41-4 ug/mL Antitubercular compound ARP4?

0.207

Antimycin12.5-50 ug/mL Antimycin A?

0.085

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.245

PA_110-50 ug/mL Antitubercular compound PA-1?

0.708

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.372

PA8240.2-2 ug/mL PA-824?

0.169

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.141

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.015

Verapamil50 uM Verapamil?

-1.219

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.203

methoxatin10-20 ug/mL Methoxatin?